Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma
Purpose:To investigate the survival outcomes and toxicities associated with the addition of nimotuzumab to concurrent chemoradiotherapy (CCRT) in locally advanced nasopharyngeal carcinoma (LANPC) patients who received induction chemotherapy (IC).Methods:Patients with stage III-IVA nasopharyngeal car...
Saved in:
Main Authors: | Run-Jie Wang (Author), Rui-Quan Ke (Author), Yi-Feng Yu (Author), Guan-Zhong Lu (Author), San-Gang Wu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy
by: Man Ao, et al.
Published: (2023) -
The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
by: Ali Yaghobi Joybari, et al.
Published: (2021) -
Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
by: Huang JF, et al.
Published: (2018) -
The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
by: Busra Yilmaz, et al.
Published: (2023) -
Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era
by: Su Z, et al.
Published: (2020)